Pfizer has agreed to acquire Metsera for $10 billion, outbidding Novo Nordisk in a heated competition. Metsera's board ...
U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results